Emergence of SARS-CoV-2 Variants and Impact on IVD Testing - CIMIT MAIN

null Emergence of SARS-CoV-2 Variants and Impact on IVD Testing

Emergence of SARS-CoV-2 Variants and Impact on IVD Testing


Speakers: 
Richard Creager, PhD
Co-Founder & Partner, NaviDx LLC

Eric Lai, PhD 
Ex-SVP at Takeda Pharmaceutical and Head of R&D at Gen-Probe Diagnostics

This webinar took place on March 23, 2021:

Watch the Recording >

Download the Slides >